Micropulse Transcleral Cyclophotocoagulation in the treatment of refractary glaucoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170325033136N2

Enrollment

100

Registered

2018-05-18

Start date

2637-09-11

Completion date

Unknown

Last updated

2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, IOP. Unspecified glaucoma

Interventions

Intervention group: the intervention group is consisted of the nontreated eye. In each patient only one eye is treated with micropulse cyclophotocoagulation, the fellow eye represents control group. T

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Intraocular pressure higher than 21 mmhg Age > 18 Signed informed consent

Exclusion criteria

Exclusion criteria: Uveitis Ocular surgery in the last 3 months, prior to study enrolment.

Design outcomes

Primary

Measure	Time frame
IOP decrease. Timepoint: 1 week, 1 month, 3 months,6 months, 1 year. Method of measurement: Goldman aplanotonometry.	—

Secondary

Measure	Time frame
Pain endurance. Timepoint: 5 minutes after procedure. Method of measurement: VAS scale.;Number of eye drops after the procedure to control the IOP. Timepoint: 1 month, 6 months, 1 year. Method of measurement: Asking patient.	—

Countries

Romania

Contacts

Public ContactAlexandra Preda

Centrul Oftalmologic Prof Dr Munteanu

alexandrapreda004@gmail.com+40 745 113 511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026